Articles tagged as "Alnylam Pharmaceuticals"
Orbis Global Cautious: A disciplined approach to risk and return
Carefully balancing risk and return has become increasingly important in an investment environment marked by volatility and uncertainty. Mark Dunley-Owen fro...
What if the real American exceptionalism now lies beyond America’s biggest stocks?
Mega-cap technology companies have come to embody America’s market might – innovative, dominant, and seemingly unstoppable. Yet history suggests that when...
Orbis Global Equity: Biotech breakthroughs in a crowded market
In an increasingly competitive and crowded market, the biotech sector offers unique opportunities to capitalise on overlooked, undervalued shares. Graeme...
